2020
DOI: 10.1002/minf.202000057
|View full text |Cite
|
Sign up to set email alerts
|

Privileged Scaffold Analysis of Natural Products with Deep Learning‐based Indication Prediction Model

Abstract: Natural products play a vital role in the drug discovery and development process as an important source of reliable and novel lead structures. But the existing criteria for drug leads were usually developed for synthetic compounds and cannot be directly applied to identify lead scaffolds from natural products. To solve this problem, we propose a method to predict indications and identify privileged scaffolds of natural products for drug design. A deep learning model was built to predict indications for natural… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
8
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 10 publications
(8 citation statements)
references
References 23 publications
0
8
0
Order By: Relevance
“…[143] Most recently, multi-task deep neural networks were trained on medical indication data and employed for identifying privileged molecular scaffolds in NPs (in this case, scaffolds for which multiple NPs built on the identical scaffold are active in the same indication). [144] Based on the predictions of these models, a privileged scaffold dataset for 100 indications was compiled that could serve as a starting point for NP-based drug discovery.…”
Section: Computational Methods For the Prediction Of The Macromoleculmentioning
confidence: 99%
“…[143] Most recently, multi-task deep neural networks were trained on medical indication data and employed for identifying privileged molecular scaffolds in NPs (in this case, scaffolds for which multiple NPs built on the identical scaffold are active in the same indication). [144] Based on the predictions of these models, a privileged scaffold dataset for 100 indications was compiled that could serve as a starting point for NP-based drug discovery.…”
Section: Computational Methods For the Prediction Of The Macromoleculmentioning
confidence: 99%
“…A clear separation between the chemical space represented by MNP when compared to TNP when exploring ML techniques was observed [ 401 ]. A Generative Topographic Mapping (GTM) for chemical data visualization was also developed [ 401 ] in order to map the terrestrial and marine origin of the NP landscape for the external test set (a data set not used to build the model, comprising 3236 MNP and 3258 TNP) for the StreptomeDB 2.0 database (2877 unique microbial NP produced by the genus Streptomyces , an actinobacterium) [ 402 ] when comparing with the Pye data set (5486 unique microbial and MNP) [ 58 , 403 , 404 , 405 , 406 ] ( Figure 10 ).…”
Section: Chemoinformatics Tools To Facilitate Drug-lead Discoverymentioning
confidence: 99%
“…Entropy-based information metrics were used to identify the privileged scaffolds for each indication, and a Privileged Scaffold Dataset (PSD) of NP was built. In Figure 12 , some examples are shown [ 403 , 404 , 405 , 406 ].…”
Section: Chemoinformatics Tools To Facilitate Drug-lead Discoverymentioning
confidence: 99%
See 1 more Smart Citation
“…In previous studies, the prediction of natural product bioactivities was commonly performed by models trained on datasets containing both human synthetic compounds and natural products [ 24 , 25 , 26 ]. Chen et al [ 27 ] managed to use structural information from conventional simple molecules to predict targets for natural products and macrocyclic ligands.…”
Section: Introductionmentioning
confidence: 99%